European Heart Journal最新文献_第3页

The gender gap following infrarenal abdominal aneurysm repair: how to close the gap? 腹内动脉瘤修复后的性别差距：如何缩小差距？

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-01-20 DOI: 10.1093/eurheartj/ehae874

Chiara Lomazzi,Jasper F de Kort,Santi Trimarchi

引用次数: 0

Correction to: 2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM). 2023 ESC心内膜炎管理指南：由欧洲心脏病学会（ESC）心内膜炎管理工作组制定，经欧洲心胸外科协会（EACTS）和欧洲核医学协会（EANM）批准。

IF 37.6 1区医学

European Heart Journal Pub Date : 2025-01-18 DOI: 10.1093/eurheartj/ehae877

引用次数: 0

The decalogue of the 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society consensus document on catheter and surgical ablation of atrial fibrillation. 2024年欧洲心律协会/心律学会/亚太心律学会/拉丁美洲心律学会共识文件关于房颤导管和手术消融的十诫。

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-01-17 DOI: 10.1093/eurheartj/ehae375

Stylianos Tzeis,Alireza Sepehri Shamloo

引用次数: 0

Familial hypercholesterolaemia: how to further improve outcomes. 家族性高胆固醇血症：如何进一步改善预后。

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-01-17 DOI: 10.1093/eurheartj/ehae834

Vera Bittner

引用次数: 0

The Kosovo Society of Cardiology: the youngest member in the ESC family. 科索沃心脏病学会：ESC家族中最年轻的成员。

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-01-17 DOI: 10.1093/eurheartj/ehae785

Gani Bajraktari

引用次数: 0

Optical coherence tomography-based management of coronary plaque erosion following immune checkpoint inhibitors. 免疫检查点抑制剂后冠状动脉斑块侵蚀的光学相干断层扫描管理。

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-01-17 DOI: 10.1093/eurheartj/ehae817

Yuma Ichikawa,Tsuyoshi Kobayashi,Akira Sato

引用次数: 0

Ages at coronary heart disease and death in familial hypercholesterolaemia: a Danish nationwide study spanning 44 years 家族性高胆固醇血症的冠心病发病年龄和死亡：丹麦一项长达44年的全国性研究

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-01-17 DOI: 10.1093/eurheartj/ehae912

Jacob Reeh, Shoaib Afzal, Anders Berg Wulff, Børge G Nordestgaard

{"title":"Ages at coronary heart disease and death in familial hypercholesterolaemia: a Danish nationwide study spanning 44 years","authors":"Jacob Reeh, Shoaib Afzal, Anders Berg Wulff, Børge G Nordestgaard","doi":"10.1093/eurheartj/ehae912","DOIUrl":"https://doi.org/10.1093/eurheartj/ehae912","url":null,"abstract":"Background and Aims Familial hypercholesterolaemia leads to lifelong elevated low-density lipoprotein cholesterol with increased risk of coronary heart disease and pre-mature death. It is unknown whether the prognosis for individuals with familial hypercholesterolaemia has improved over the past four decades as registration of this condition has been limited worldwide. However, in Danish nationwide registries, modified ICD coding has allowed such registration since 1978. This study tested the hypothesis that age at death and coronary heart disease has improved from 1978 to 2021 in individuals with vs. those without familial hypercholesterolaemia. Methods From nationwide registries, all Danish residents were included in a retrospective cohort study. Inclusion and follow-up were from 1978 to 2021. Individuals diagnosed with familial hypercholesterolaemia were identified, and trends over time were examined for age at death and age at coronary heart disease. Results During follow-up for those with (n = 10 199) and without (n = 9 174 926) familial hypercholesterolaemia, 27% and 27% died and 34% and 9% experienced coronary heart disease. Age at death was 22 years younger in 1978 (P &lt; .001) but similar in 2021 (P = .16) in individuals with vs. without familial hypercholesterolaemia. Although the corresponding age at coronary heart disease was 20 years younger in 1978 (P &lt; .001), it was still 7 years younger in 2021 (P &lt; .001) in individuals with vs. without familial hypercholesterolaemia. These results were similar in women and men and in a 1:100 matched analysis by sex, ethnicity, and time of birth. Conclusions Nationwide from 1978 to 2021 in Denmark, normalization of age at death but not age at coronary heart disease was observed for individuals diagnosed with familial hypercholesterolaemia.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"7 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142988660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Long-term pulse pressure trajectories and risk of incident atrial fibrillation: the Tromsø Study 长期脉压轨迹和房颤发生的风险：特罗姆瑟研究

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-01-17 DOI: 10.1093/eurheartj/ehaf005

Ekaterina Sharashova, Eva Gerdts, Jocasta Ball, Renate B Schnabel, Michael Stylidis, Sweta Tiwari, Ellisiv B Mathiesen, Tom Wilsgaard, Maja-Lisa Løchen

{"title":"Long-term pulse pressure trajectories and risk of incident atrial fibrillation: the Tromsø Study","authors":"Ekaterina Sharashova, Eva Gerdts, Jocasta Ball, Renate B Schnabel, Michael Stylidis, Sweta Tiwari, Ellisiv B Mathiesen, Tom Wilsgaard, Maja-Lisa Løchen","doi":"10.1093/eurheartj/ehaf005","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf005","url":null,"abstract":"Background and Aims Sex-based differences in the association of long-term trends in pulse pressure with future risk of atrial fibrillation (AF) have been explored using data from the population-based Tromsø Study 1986–2016. Methods Women (n = 8331) and men (n = 7638) aged ≥20 years who attended at least two of the three Tromsø Study surveys conducted between 1986 and 2001 (the exposure period) were followed up for incident AF throughout 2016 (the follow-up period). Pulse pressure ≥60 mmHg was considered elevated. Group-based trajectory modelling and Cox regression were used for statistical analyses. Results Three long-term trajectory groups for pulse pressure were identified: Group 1 had normal pulse pressure throughout the exposure period, Group 2 had normal pulse pressure at the beginning and elevated pulse pressure at the end of the exposure period, and Group 3 had elevated pulse pressure throughout. Over the follow-up period, 568 (6.8%) women and 798 (10.5%) men developed AF. After adjustment for potential confounders at baseline, the long-term trajectory groups for elevated pulse pressure were associated with increased risk of AF in women, but not in men. In women, the adjusted hazard ratios of AF were 1.60 (95% confidence interval: 1.23, 2.09) for trajectory Group 2 and 2.78 (1.93, 4.02) for trajectory Group 3, compared with Group 1. Conclusions Long-term elevated pulse pressure trajectories were independently associated with increased risk of AF in women, but not in men. Our findings call for further investigations to understand the mechanisms behind these sex-based differences.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"27 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142988661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Navigating cardiotoxicity risk in cancer therapy: the importance of the HFA-ICOS score. 在癌症治疗中导航心脏毒性风险：HFA-ICOS评分的重要性。

IF 37.6 1区医学

European Heart Journal Pub Date : 2025-01-16 DOI: 10.1093/eurheartj/ehae624

Lloyd E Butel-Simoes, Doan T M Ngo, Aaron L Sverdlov

引用次数: 0

Correction to: Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score. 更正：蒽环类药物诱发的心血管毒性：心力衰竭协会和国际心肿瘤协会风险评分的验证。

IF 37.6 1区医学

European Heart Journal Pub Date : 2025-01-16 DOI: 10.1093/eurheartj/ehae818

引用次数: 0